Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

This study is currently recruiting participants.

Verified by Drexel University, May 2008

Sponsors and Collaborators:	Drexel University MDA/ALS Center of Hope
Information provided by:	Drexel University
ClinicalTrials.gov Identifier:	NCT00718016

Purpose

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Condition
Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Neurodegenerative Disease Motor Neuron Disease

Genetics Home Reference related topics: amyotrophic lateral sclerosis familial paroxysmal nonkinesigenic dyskinesia

MedlinePlus related topics: Amyotrophic Lateral Sclerosis Degenerative Nerve Diseases

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Cross-Sectional
Official Title:	Assessment of the Cyberlink Control System for Use by the ALS Patient

Further study details as provided by Drexel University:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	25
Study Start Date:	December 2004
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Groups/Cohorts
ALS Subjects having either definite or probable ALS by El Escorial Criteria.

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

ALS clinic patients at MDA/ALS Center of Hope.

Criteria

Inclusion Criteria:

Those aged 18-75 diagnosed with probable or definite ALS.

Exclusion Criteria:

Those with decision impairment will not be considered.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00718016

Locations

United States, Pennsylvania
MDA/ALS Center of Hope	Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contact: Christine Barr, RN 215-762-5186 cbarr@drexelmed.edu
Principal Investigator: Terry Heiman-Patterson, MD

Sponsors and Collaborators

Drexel University

MDA/ALS Center of Hope

Investigators

Study Director:

Terry Heiman-Patterson, MD

MDA/ALS Center of Hope

More Information

Responsible Party:	MDA/ALS Center of Hope ( Terry Heiman-Patterson, MD )
Study ID Numbers:	Internal-903
Study First Received:	July 14, 2008
Last Updated:	July 16, 2008
ClinicalTrials.gov Identifier:	NCT00718016
Health Authority:	United States: Institutional Review Board

Keywords provided by Drexel University:

Amyotrophic Lateral Sclerosis
Cerebrospinal Fluid
Neurodegenerative Disease
Motor Neuron Disease

Autonomic Nervous System
Neurodegenerative Diseases
Movement Disorders

Study placed in the following topic categories:

Amyotrophic lateral sclerosis
Neuromuscular Diseases
Spinal Cord Diseases
Movement Disorders
Amyotrophic Lateral Sclerosis
Central Nervous System Diseases

Lou Gehrig's disease
Sclerosis
Degenerative motor system disease
Neurodegenerative Diseases
Motor neuron disease
Motor Neuron Disease

Additional relevant MeSH terms:

Pathologic Processes
Nervous System Diseases

ClinicalTrials.gov processed this record on January 13, 2009